OrphaCare, a global specialist in the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new managing director. He succeeds Georg Fischer. In this role, the experienced medical technology expert will focus on expanding the company’s strategic scope and initiating the next phase of growth. OrphaCare plays a central role in supporting AOP Health’s integrated therapeutic approach as well as the Group’s long-term expansion.
Andreas Goppelt brings more than 25 years of leadership experience in the medical technology, biotechnology, and pharmaceutical industries. He has a proven track record of driving innovation, scaling global organizations, and achieving growth in highly regulated healthcare markets.
In his new role, Goppelt will drive OrphaCare’s expansion through a combination of geographic growth and portfolio expansion by further developing an innovative product pipeline and pursuing targeted mergers and acquisitions.
Goppelt will prioritize organizational agility, digital transformation, and operational excellence. At the same time, he will foster a performance-driven corporate culture based on accountability, collaboration, and personal responsibility.
